Men, fasting plasma triglyceride (mmol/L) | Women, fasting plasma triglyceride (mmol/L) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 1.21 | 1.21 ~ | 1.7 ~ | 2.83 ~ | > 5.6 | P for trendb | < 1.21 | 1.21 ~ | 1.7 ~ | 2.83 ~ | > 5.6 | P for trendb | |
No. of participants | 4293 | 3040 | 3335 | 1546 | 343 | 6023 | 2661 | 2353 | 747 | 97 | ||
Hyperuricemiac | ||||||||||||
Cases | 225 | 249 | 387 | 300 | 91 | 146 | 154 | 241 | 133 | 14 | ||
Rate (%) | 5.2 | 8.2 | 11.6 | 19.4 | 26.5 | 2.4 | 5.8 | 10.2 | 17.8 | 14.4 | ||
Model 1, OR (95% CI) | 1.00 | 1.61 (1.34–1.94) | 2.37 (2.00–2.82) | 4.35 (3.62–5.23) | 6.53 (4.96–8.59) | 0.000 | 1.00 | 2.47 (1.96–3.12) | 4.59 (3.72–5.68) | 8.72 (6.80–11.19) | 6.79 (3.77–12.24) | 0.000 |
Model 2, OR (95% CI) | 1.00 | 1.62 (1.35–1.96) | 2.37 (2.00–2.81) | 4.26 (3.54–5.12) | 6.26 (4.76–8.25) | 0.000 | 1.00 | 2.35 (1.86–2.97) | 4.28 (3.44–5.33) | 8.16 (6.33–10.53) | 6.43 (3.56–11.61) | 0.000 |
Model 3, OR (95% CI) | 1.00 | 1.46 (1.21–1.77) | 1.99 (1.65–2.39) | 3.10 (2.51–3.82) | 4.27 (3.13–5.83) | 0.000 | 1.00 | 1.95 (1.53–2.50) | 3.20 (2.51–4.08) | 5.42 (4.03–7.28) | 4.01 (2.13–7.55) | 0.000 |